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ABSTRACT
Nicotine has been identified as one of the causal factor for oxidative stress, hypertension and hyperlipidemia. Roselle 
has been widely studied for its potential as an antioxidant, antihyperlipidemic and antihypertensive. However, no studies 
have been done to investigate if roselle could diminish the oxidative stress caused by nicotine which could further lead 
to cardiac damages. Thus, this study was aimed to investigate the effect of roselle extract (HSE) on blood pressure, 
serum lipid profile, oxidative stress marker levels and histological changes to the heart in nicotine-treated rats. A total 
of 21 Sprague-Dawley rats were randomly divided into 3 groups (n=7 per group): Control group received normal 
saline (0.5 mL/day, i.p); nicotine group received 0.6 mg/kg/BW nicotine (i.p); and treated group received 100 mg/kg/b.w 
HSE through oral force feeding followed with 0.6 mg/kg/b.w nicotine (i.p) for 21 consecutive days. The results showed 
that HSE significantly (p>0.05) reduced the heart rate but no effect to the blood pressure.  For lipid profile study, HSE 
increased the high-density lipoprotein (HDL) concentration significantly (p<0.05) in rats given with nicotine, without 
any significant changes in total cholesterol, triglyceride and low-density ipoprotein (LDL) concentration.  Besides, HSE 
treatment was also found to reverse malondialdehyde (MDA) level, superoxide dimustase (SOD) enzyme  activity and protein 
concentration significantly (p<0.05) in nicotine-treated rats. In summary, these results indicated that HSE is an effective 
antioxidant against oxidative damage in heart caused by nicotine, but not as antihyperlipidemic and antihypertensive 
agent in this rat model. 
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ABSTRAK
Nikotin telah dikenal pasti sebagai salah satu faktor penyebab untuk tekanan  oksida, hipertensi dan hiperlipidemia. 
Rosel telah dikaji secara meluas kerana potensinya sebagai antioksidan, antihiperlipidemik dan antihipertensi. 
Namun begitu, tiada lagi kajian setakat ini yang mengkaji sama ada rosel mampu merendahkan tekanan oksida 
yang disebabkan oleh nikotin yang kemudiannya boleh membawa kepada kerosakan jantung. Dengan itu, kajian ini 
telah dijalankan untuk menentukan kesan ekstrak rosel (HSE) pada tekanan darah, profil lipid serum, aras penanda 
tekanan oksida dan perubahan histologi jantung tikus  terawat-nikotin. Sebanyak 21 tikus Sprague-Dawley telah 
dibahagikan secara rawak kepada 3 kumpulan (n=7 setiap kumpulan): Kumpulan kawalan yang menerima salina 
normal (0.5 mL/hari, i.p); kumpulan nikotin yang menerima 0.6 mg/kg/BW nikotin (i.p.); dan kumpulan rawatan yang 
menerima 100 mg/kg/BW HSE secara paksaan oral diikuti dengan 0.6 mg/kg/BW nikotin (i.p) selama 21 hari berturut-
turut. Hasil kajian menunjukkan bahawa HSE menurunkan kadar denyutan jantung secara signifikan (p>0.05) tetapi 
tiada kesan pada tekanan darah. Bagi profil lipid pula, HSE mampu meningkatkan aras lipoprotein berketumpatan 
tinggi dengan signifikan (p<0.05) pada tikus diberi nikotin, namun tanpa sebarang perubahan signifikan pada aras 
kolesterol jumlah, trigliserida dan lipoprotein berketumpatan rendah. Selain itu, rawatan HSE juga didapati mampu 
untuk memperbaiki aras malondialdehid (MDA), aktiviti enzim superoksida dismutase (SOD) dan kepekatan protein 
secara signifikan (p<0.05) pada tikus terawat-nikotin.  Secara kesimpulannya, hasil kajian ini telah menunjukkan 
bahawa HSE adalah antioksidan yang berkesan terhadap kerosakan  oksida oleh nikotin pada jantung, namun bukan 
sebagai agen antihipertensi dan antihipersif di dalam model tikus ini.
Kata kunci: Nikotin; Rosel; tekanan darah; tekanan oksida
INTRODUCTION
Nicotine, an alkaloid isolated from the tobacco leaves, is 
usually found in cigars and cigarettes (Efraim et al. 2000). 
According to Joukar et al. (2012), smoking is one of the 
contributing factors for hypertension and atherosclerosis 
that lead to cardiovascular diseases. Nicotine enhances 
the process of lipolysis that releases plasma free fatty 
acids and further accelerates the synthesis of cholesterol, 
triglyceride, very low-density lipoprotein (VLDL) and low-
density lipoprotein (LDL) (Helen et al. 2000). In addition, 
high concentration of LDL will lead to development of 
atherosclerosis by stimulating LDL oxidation in the arterial 
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wall (Sreekala & Indira 2008). Activation of sympathetic 
activity triggered by nicotine could also lead to increased 
heart rate and vasoconstriction, thus elevates the blood 
pressure (Talukder et al. 2011; William 2013). This could 
be caused by the decreased production of nitric oxide 
(NO) due to excessive free radicals due to nicotine intake, 
leading to systemic vasoconstriction and hypertension 
(Zainalabidin et al. 2014). Subsequently, hypertension 
could lead to other complications such as left ventricular 
hypertrophy and heart failure (Lip et al. 2000). 
 Nicotine has been shown to cause oxidative stress 
which increases reactive oxygen species (ROS) and lipid 
peroxidation (Suleyman et al. 2002). Oxidative stress could 
cause heart failure through impairment of mitochondrial 
respiration that reduces ATP production and necrosis 
(Kunwar & Priyadarshini 2011; Nojiri et al. 2006). Lipid 
peroxidation in the heart causes Ca2+ overload that triggers 
development of atherosclerosis, hypertension, cardiac 
hyperthrophy and heart failure (Jamaludin 2008). This Ca2+ 
release from sarcoplasmic reticulum is by the reaction of 
superoxide, hydroxyl (OH) and NO with sulfhydryl groups 
in the heart (Valko et al. 2007). The increase of lipid 
peroxidation in nicotine-induced rats showed abolished 
antioxidant enzyme activities such as catalase (CAT) and 
superoxide dismutase (SOD) (Helen et al. 2000; Joukar et 
al. 2012). ROS produced in the cells were physiologically 
removed by endogenous antioxidant, a primary means 
to prevent cellular damage (Leiris et al. 2006). Thus, 
exogenus source of antioxidant has been considered as 
one approach to balance this oxidative redox status.
 Roselle (Hibiscus sabdariffa) is a local tropical plant 
which offers a wide range of nutraceutical benefits. It is 
characterized by red calyces which is rich in antioxidant 
components, mainly anthocyanin, that counteracts with 
oxidative damages by scavenging the hydroxyl radicals, 
donating electron to free radicals and terminating radical 
chain reaction (Cissouma et al. 2013). Besides that, 
unique sour taste in roselle extract indicates that roselle 
contains phenolic acid components, such as hibiscus acid 
that has the ability to prevent carbohydrate metabolism 
and absorption, as well as inhibit lipolysis (El-Shafey et 
al. 2013). In a clinical study on hypertensive subjects, 
it was found that roselle could reduce mean arterial 
pressure (MAP), comparable  to the effect of captopril, an 
antihypertensive drug (Harerra-Arellano et al. 2004). The 
antihypertensive activity of roselle could be possibly via 
the inhibition of angiotensin-converting enzyme activity 
(ACE) (Ojeda et al. 2010), enhancement of vascular activity 
by Na+-K+-ATPase and Ca2+-Mg2+-ATPase (Olatunji et al. 
2006) or by increment of NO production, an endothelium-
derived relaxing factor (EDRF) (Ajay et al. 2006). 
 In spite of all these evidences, little is known about 
the effects of roselle on nicotine-induced heart damage. We 
hypothesized that roselle has protective potential towards 
heart damages caused by nicotine. Therefore, this study 
was aimed to investigate the effects of roselle extract 
(HSE) on blood pressure, serum lipid profile, oxidative 
stress marker level and histological changes to the heart 
in nicotine-treated rats. 
MATERIALS AND METHODS
PREPARATION OF ROSELLE AQUEOUS EXTRACT
Dried roselle (H. sabdariffa L. UKMR-1) calyces 
were collected from Kuala Berang, Terengganu and 
authenticated by a plant taxonomist at Herbarium Unit, 
Universiti Kebangsaan Malaysia (UKM) and were deposited 
as voucher specimen UKMB 40308. Roselle aqueous 
extract was prepared based on the method by Jamaludin 
et al. (2013). First, dried calyces were added to distilled 
water in a 1:2 ratio and ground with blender (Cornell, 
Malaysia) for 10 min. After that, the roselle extract was 
heated until it boiled and allow to cool. Cooled extract 
solution was filtered and then the filtrate was kept frozen 
in an aluminium-wrapped round bottle flask overnight at 
-20°C before freeze-dried (Heto-Holten A/S, Denmark) and 
stored in a dark bottle at 4°C until use. From a 250 g dried 
calyx, a total yield 42.8 g of extract powder was obtained. 
ANIMALS AND EXPERIMENTAL DETAILS
Sprague-Dawley male rats (270-300 g) were obtained from 
Laboratory Animal Resource Unit, Universiti Kebangsaan 
Malaysia (UKM). The animal ethic was approved by UKM 
Animal Ethic Committee (FSK/Biomed/2012/Satirah/12-
Dec./488/-Dec.-2012-Dec-2014). The animals were kept 
in cages of 2 rats per cage and maintained under standard 
conditions at 12 h light and 12 h dark cycle. They were fed 
on standard rat chow and water ad libitum. Twenty-one rats 
were randomly divided into 3 groups: Group I (Control): 
Rats were given 0.5 mL/day normal saline, (i.p); Group II 
(Nicotine): Rats were given 0.6 mg/kg BW nicotine, (i.p) 
(Helen et al. 2000); and Group III (Nicotine + HSE): Rats 
were given 100 mg/kg BW HSE (oral gavage) (Idris et al. 
2012) + 0.6 mg/kg BW nicotine, (i.p).
 The regimens were continued for 21 consecutive days 
(Helen et al. 2000). Blood pressure was taken on day-0 
and day-21 by using CODA II TM Non-Invasive Blood 
Pressure (NIBP) System (Kent Scientific Corporation, 
USA). At the end of the experiment, the rats were deprived 
of food overnight. On day-22, under the light anesthesia 
by diethyl ether, blood sample was taken via orbital sinus 
and centrifuged for serum separation. Serum was then 
stored at -40oC for lipid profile analysis. The hearts were 
excised, washed with cold 1.15% KCl and then weighed. 
The heart tissue was homogenized in 10 mL of 1.15% KCl 
(ice-cold) and centrifuged at 6000 g, 15 min at 4oC. After 
centrifuge, the clear supernatant solution was stored at 
-40oC for biochemical analysis.
LIPID PROFILE
Serum total cholesterol (TC), high-density lipoprotein 
(HDL) and triglyceride (TG) levels were measured by using 
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semi-automated biochemical analyzer Biosystem BTS 350 
(BioSystem Reagent & Instrument, USA). LDL is calculated 
according to Friedewald et al. (1972). Besides, atherogenic 
index (TC/HDL) and predictive indicator of cardiovascular 
disease (CVD) (LDL/HDL) were calculated according to 
Leimieux et al. (2001).
OXIDATIVE MARKER & ANTIOXIDANT ACTIVITY
The production of MDA was measured for lipid peroxidation 
based on the Stocks and Dormandy (1971) methods. Briefly, 
heart sample homegenate was added to a trichloroacetic 
acid/hydrochloric acid (TCA/HCl) solution, vortexed and 
incubated at room temperature for 15 min. The mixture 
was added to thiobarbituric acid/sodium hydroxide (TBA/
NaOH), vortexed and heated in a boiling water bath (100°C) 
for 30 min. The MDA in the heart sample reacted with the 
TBA to form a pink chromogen containing thiobarbituric 
acid reactive substances (TBARS). The level of TBARS in 
the heart sample was measured using a spectrophotometer 
at 532 nm. The MDA concentration was expressed as nM/
mg of protein. 
 Superoxide dismutase (SOD) enzyme activity was 
determined using the Beyer and Fridovich (1987). Briefly, 
heart sample homogenate was mixed with the substrate 
containing PBS (EDTA), L-methionine, nitroblue tetrazolium 
chloride (NBT.2HCl) and Triton-X and mixed together with 
riboflavin. The mixture was incubated in an aluminium 
box under 20 Watt lamp for 7 min. The SOD activity was 
measured spectrometrically by monitoring the inhibition 
of ferricytochrome reduction using a xanthine-xanthine 
oxidase as a source of peroxides. SOD unit is defined as 
one unit of enzyme, which inhibits 50% of the nitro blue 
tetrazolium (NBT) reduction. SOD activity was calculated 
and expressed in U/mg protein.
 Reduced glutathion (GSH) content was measured based 
on the Ellman (1959) method with some modification 
where 415 nm was replaced with 412 nm. Heart sample 
homogenate was mixed with a reaction buffer at pH8.0 
and 5,5’-dithiobase-2-nitrobenzene (DTNB) for 15 min and 
measured at 412 nm by using a microplate reader. The GSH 
content was expressed as mmol/mg protein.
 Protein concentrations in the plasma were measured 
by the method of Lowry et al. (1951). Briefly, plasma was 
added to Lowry stock reagent and incubated for 30 min at 
27°C. Then, Follin-Phenol 2N was added, vortexed and 
incubated again for 30 min at 27°C. The level of protein 
was measured by using spectrophotometer at 595 nm. The 
protein level was expressed as mg/mL. 
HISTOLOGY
Histological observation of the heart was performed using 
Hematoxylin and Eosin (H&E) staining method.
STATISTICAL ANALYSIS
The results were presented as mean ± SEM. Biochemical 
data were analyzed by One-Way ANOVA while blood 
pressure data were analyzed using Mixed-ANOVA. All 
data were tested for normality using the Shapiro-Wilk test 
(p>0.05) and Levene’s test was used to assess homogeneity 
(p>0.05). P-value ≤ 0.05 was considered as statistically 
significant.
RESULTS
At the end of experiment, there was no significant 
difference in the rats body weight among the three groups 
(p>0.05) (Table 1). 
 Table 2 shows the blood pressure monitoring at 
day-0 and day-21. The basic parameters at the initial 
experiment were consistent between all groups (day-0). 
At day-21, there was no significant difference in the blood 
pressure parameters; namely systolic, diastolic and mean 
arterial pressure. However, the heart rate in nicotine + 
HSE decreased significantly compared to nicotine group 
(p<0.05). 
TABLE 2. Blood pressure and heart rate monitoring  before and after treatment 
Group SBP (mmHg) DBP (mmHg) MAP (mmHg) HR (bpm)
Day-0 Day-21 Day-0 Day-21 Day-0 Day-21 Day-0 Day-21
Control
Nicotine
Nicotine + HSE
115.00±2.90
118.00±0.87
121.00±3.21
120.00±4.90
124.00±0.99
110.00±3.50
87.33±3.30
88.58±2.30
84.00±5.80
86.17±2.12
88.76±2.11
80.50±2.36
96.44±3.03
98.16±1.88
95.83±4.69
97.33±2.90
100.00±1.28
88.83±1.36
360.00±8.47
363.00±3.80
358.00±7.10
380.00±10.81
400.00±6.36
336.00±0.60b 
b p<0.05 vs. nicotine group
TABLE 1. Body weight parameter before and after treatment
Group Body weight (g)
Day- 0 Day-21
Control
Nicotine
Nicotine + HSE
274.86±5.06
261.86±4.82
269.14±6.58
310.00±5.00
297.86±5.87
295.00±8.77
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 The serum lipid profile showed no significant changes 
in TC, TG and LDL level. However, the HDL level was 
decreased in nicotine group, and elevated in nicotine + 
HSE group (p<0.05) (Table 3). The atherogenic index 
(Figure 1) and predictive indicator for CVD (Figure 2) were 
significantly increased in nicotine group vs. control group 
and decreased in nicotine + HSE group vs. nicotine group 
(p<0.05). 
 MDA concentration was significantly increased in 
nicotine group vs. control and nicotine + HSE (Figure 3). 
Nicotine + HSE group showed an increase in SOD enzyme 
activity significantly (p<0.05) as compared to control and 
nicotine group (Figure 4). GSH concentration showed no 
significant difference (p>0.05) in all groups (Figure 5). 
Meanwhile, protein concentration was significantly higher 
in nicotine + HSE group as compared to nicotine group 
(Figure 6). 
HISTOLOGY
Histological observation of the left ventricular tissue 
appeared normal in all groups. The nicotine induction failed 
to cause any morphological changes (Figure 7). 
DISCUSSION
Our study has shown that Hibiscus sabdariffa extract 
(HSE) was able to protect the heart damage from nicotine 
by elevating antioxidant enzymes and reducing oxidative 
stress levels. Nicotine, which is the main psychoactive 
TABLE 3. Serum lipid profile
Group TC (mmol/L) TG (mmol/L) HDL (mmol/L) LDL (mmol/L)
Control
Nicotine
Nicotine + HSE
1.65±0.09
1.71±0.07
1.66±0.08
0.37±0.08
0.59±0.12
0.35±0.05
0.50±0.04
0.31±0.03a
0.74±0.05a,b
1.01±0.14
1.13±0.10
0.77±0.14 
a p<0.05 vs. control group  b p<0.05 vs. nicotine group
FIGURE 1. Atherogenic index (TC/HDL) of heart tissue 
Values are means ± SEM
FIGURE 2. Predictive indicator for CVD (LDL/HDL) of heart tissue 
Values are means ± SEM
FIGURE 3. Malondialdehyde (MDA) content of heart tissue 
Values are means ± SEM
FIGURE 4. SOD enzyme activity of heart tissue 
Values are means ± SEM
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compound in cigarette, has been identified as the factor 
that causes cardiovascular diseases such as hypertension, 
atherosclerosis and myocardial ischemia (Yoshikawa & 
Naito 2002). According to Gomes et al. (2004), 0.6 mg/kg/
day dose of nicotine in a rat is similar to the dose in light 
smoker (low dose), while a heavy smoker is equivalent to 
1.2 mg/kg/day dose of nicotine (high dose). In rat, the LD50 
of nicotine through intraperitoneum injection was found at 
14.6 mg/kg of body weight (Karaconji 2005). Thus, this 
has proven that the nicotine dosage used in this study was 
considered as safe. 
 Smoking is often associated with weight loss as 
nicotine can increase metabolic rate and stimulate leptin 
which gives a feeling of fullness (McGovern & Benowitz 
2011). However, in this present study, nicotine did not 
change the body weight increment among the groups, 
similarly found in other studies (Iranloye & Bolarinwa 
2009; Olatunji et al. 2006). This was probably due to low 
dose of nicotine (0.6 mg/kg) that did not affect the amount 
of food intake (Iranloye & Bolarinwa 2009). 
 Heart rate can increase up to 30% during the first 10 min 
of smoking. This is because nicotine activates sympathetic 
nervous system by binding to nicotinic acetylcholine 
receptor (nAChR) and stimulates adrenaline release that 
increases the heart rate, blood pressure and respiratory rate 
(William 2013). In this study, HSE was found to decrease 
the heart rate significantly in nicotine-exposed rats. The 
mechanism involved is not fully understood yet, but it 
might work like conventional medicine (beta blocker) by 
the blocking the effect of catecholamine. This action could 
prevent the coupling of beta-receptor (β-receptor) with 
G-proteins, thus block the Ca2+ entry into cardiac myocytes 
and subsequently reducing the heart contraction and heart 
rate (Opie 1997). We did not find any significant changes 
in systolic and diastolic blood pressure in all groups. 
Probably, the nicotine dose was inadequate to increase 
the blood pressure (Benowitz et al. 2002; Shahrokhi et al. 
2006), thus hinder the antihypertensive activity of HSE. 
Supposedly, Roselle is able to lower blood pressure through 
enhancement of vascular Na+-K+-ATPase activity that 
inhibit Ca2+ entry and storage intracellularly (Olatunji et al. 
2006). Our lipid profile has found there were no significant 
changes in the levels for TG, TC and LDL in all of the groups 
and that is similar with the previous studies (Joukar et al. 
2012; Sun et al. 2001). A clinical study by Mohagheghi et 
al. (2011) on hypertensive patients, whereby 500 mg/kg 
of HSE was given for 30 days did not show any significant 
reduction in lipid profile reading. In contrary, another study 
which used the same dosage but with longer duration of 
10 weeks was found to significantly lower the TG, TC and 
LDL level in hyperlipidemic rabbits (Chen et al. (2003). 
Roselle contains protocatechuic acid that is supposed to 
inhibit lipase and HMG-CoA enzyme on lipolysis activities 
(Hopkins et al. 2013; Sari et al. 2013). This probably caused 
FIGURE 5. GSH content of heart tissue 
Values are means ± SEM. No significant difference was 
observed in any of the groups FIGURE 6. Protein concentration of heart tissue Values are means ± SEM
FIGURE 7. Photographs of the left ventricle (H&E) in (a) Control, (b) Nicotine and
(c) Nicotine + HSE under 40× magnification. No difference was seen among the groups
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the significant decrease in serum HDL concentration in HSE 
treatment compared to control and nicotine groups. HDL 
is important to uptake excess cholesterol from plasma to 
the liver, thus reducing the risk of atherosclerosis (Cho 
2009). Supportively, the atherogenic index and predictive 
indicator for CVD in our study were found significantly 
decreased with HSE treatment in nicotine-exposed rats.
 Nicotine could also aggravate oxidative stress and 
generate free radicals which attack the lipid membrane 
of cells, resulting in the formation of malondialdehyde 
(MDA) (Balakrishnan & Menon 2007; Chattopadhyay 
& Chattopadhyay 2008). Our study has shown that 
the high MDA concentration in nicotine rats was 
significantly reversed by HSE treatment, similarly 
found by Hirunpanich et al. (2006) and Al-Kennany 
& Al-Khafaf (2010). Lipid peroxidation could cause 
depletion of antioxidant SOD activity which in longer 
period could then lead to heart failure (Nojiri et al. 2006). 
When nicotine rats were treated with HSE, SOD activity 
increased significantly which was similarly observed by 
Suleyman et al. (2002). This result might be caused by the 
antioxidant components of Roselle, mainly anthocyanin, 
which removes free radicals, donating electron to free 
radicals and terminating the radical chain reaction (Dai 
& Mumper 2010; El-Shafey et al. 2013). Jain and Flora 
(2012) stated that, aggravated lipid peroxidation can cause 
a decrease in GSH, as it is also involved in reducing lipid 
peroxidation. However, we have found that there was no 
significant difference in GSH concentration for all groups. 
This could be caused by other antioxidant enzymes such 
as SOD which quickly reacts with free radicals, as it is the 
first antioxidant produced in radical chain reaction. Lipid 
peroxidation does not only damage lipid component but 
also protein level (Noeman et al. 2011). In the present 
study, HSE treatment was found to significantly increase 
the protein level compared to nicotine group. This 
is consistent with previous study that stated reduced 
protein concentration was due to liver damage induced 
by peroxidation, which interferes with protein synthesis 
(Olorunnisola et al. 2012). 
 In summary, this study demonstrates that HSE 
treatment could reduce the heart rate, the risk of 
atherosclerosis and prevent oxidative damage to the 
heart tissue, suggesting its potential as functional food to 
prevent heart damage induced by nicotine. On a separate 
note, the molecular mechanisms underlying protective 
action of roselle against heart damage requires further 
investigation. 
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